 Marsha Anderson
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucocutaneous Lymph Node Syndrome | 16 | 2020 | 76 | 2.330 |
Why?
| | Immunoglobulins, Intravenous | 6 | 2020 | 122 | 0.610 |
Why?
| | Infliximab | 3 | 2019 | 94 | 0.420 |
Why?
| | Internship and Residency | 3 | 2023 | 932 | 0.270 |
Why?
| | Pediatrics | 4 | 2018 | 983 | 0.250 |
Why?
| | Diagnostic Errors | 2 | 2008 | 148 | 0.250 |
Why?
| | Fever | 3 | 2020 | 279 | 0.240 |
Why?
| | Coronary Aneurysm | 2 | 2019 | 11 | 0.230 |
Why?
| | Benzazepines | 1 | 2004 | 37 | 0.230 |
Why?
| | Nasopharynx | 3 | 2015 | 62 | 0.220 |
Why?
| | Coronary Vessels | 3 | 2018 | 227 | 0.210 |
Why?
| | Adjuvants, Immunologic | 1 | 2004 | 206 | 0.210 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2004 | 278 | 0.210 |
Why?
| | Child, Preschool | 16 | 2020 | 9079 | 0.200 |
Why?
| | Child | 17 | 2023 | 18350 | 0.180 |
Why?
| | Circulating MicroRNA | 1 | 2020 | 24 | 0.170 |
Why?
| | Climate Change | 1 | 2021 | 127 | 0.160 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 370 | 0.160 |
Why?
| | Infant | 12 | 2020 | 7934 | 0.160 |
Why?
| | Steroids | 1 | 2019 | 145 | 0.160 |
Why?
| | Neutrophils | 1 | 2004 | 1163 | 0.160 |
Why?
| | Diagnostic Tests, Routine | 1 | 2019 | 87 | 0.160 |
Why?
| | Respiratory Tract Infections | 2 | 2015 | 319 | 0.160 |
Why?
| | Immunologic Factors | 1 | 2019 | 220 | 0.140 |
Why?
| | Faculty, Medical | 3 | 2018 | 228 | 0.140 |
Why?
| | Decision Support Systems, Clinical | 1 | 2020 | 176 | 0.140 |
Why?
| | Career Choice | 1 | 2018 | 177 | 0.130 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 372 | 0.130 |
Why?
| | Calcitonin | 1 | 2015 | 23 | 0.120 |
Why?
| | Physician Executives | 2 | 2018 | 33 | 0.120 |
Why?
| | Particulate Matter | 1 | 2016 | 185 | 0.120 |
Why?
| | Immunoglobulins | 1 | 2015 | 143 | 0.120 |
Why?
| | Echocardiography, Doppler | 1 | 2015 | 92 | 0.120 |
Why?
| | Coronary Artery Disease | 3 | 2018 | 607 | 0.110 |
Why?
| | Rhinovirus | 2 | 2015 | 40 | 0.110 |
Why?
| | Algorithms | 1 | 2020 | 1468 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2016 | 374 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1178 | 0.100 |
Why?
| | Humans | 25 | 2023 | 114714 | 0.100 |
Why?
| | Colorado | 7 | 2015 | 4086 | 0.100 |
Why?
| | Accreditation | 2 | 2023 | 76 | 0.100 |
Why?
| | Leadership | 2 | 2018 | 292 | 0.100 |
Why?
| | Gastroenteritis | 1 | 2013 | 65 | 0.100 |
Why?
| | Treatment Failure | 1 | 2013 | 332 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 359 | 0.100 |
Why?
| | Coronavirus | 2 | 2015 | 40 | 0.100 |
Why?
| | Program Development | 2 | 2018 | 342 | 0.100 |
Why?
| | Liver Function Tests | 1 | 2011 | 103 | 0.090 |
Why?
| | Male | 16 | 2020 | 55558 | 0.090 |
Why?
| | Aspirin | 1 | 2013 | 324 | 0.090 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 299 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 954 | 0.090 |
Why?
| | Female | 15 | 2020 | 59485 | 0.080 |
Why?
| | Curriculum | 2 | 2021 | 824 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2013 | 532 | 0.080 |
Why?
| | Retrospective Studies | 8 | 2018 | 12512 | 0.080 |
Why?
| | Picornaviridae Infections | 1 | 2008 | 30 | 0.080 |
Why?
| | Mentors | 1 | 2010 | 156 | 0.080 |
Why?
| | Enterovirus Infections | 2 | 2008 | 160 | 0.080 |
Why?
| | Liver Diseases | 1 | 2011 | 254 | 0.080 |
Why?
| | Enterovirus A, Human | 1 | 2007 | 12 | 0.070 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2008 | 147 | 0.070 |
Why?
| | Logistic Models | 2 | 2018 | 1843 | 0.070 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2007 | 63 | 0.070 |
Why?
| | Antibodies, Monoclonal | 1 | 2013 | 1270 | 0.070 |
Why?
| | Hospitals, Pediatric | 3 | 2019 | 479 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2020 | 1340 | 0.070 |
Why?
| | Virus Diseases | 1 | 2008 | 195 | 0.070 |
Why?
| | Clinical Competence | 2 | 2023 | 896 | 0.060 |
Why?
| | Medical Records | 2 | 2018 | 153 | 0.060 |
Why?
| | Education, Medical, Undergraduate | 1 | 2007 | 159 | 0.060 |
Why?
| | Medical Audit | 1 | 2005 | 75 | 0.060 |
Why?
| | Disease Outbreaks | 1 | 2007 | 309 | 0.060 |
Why?
| | CD11b Antigen | 1 | 2004 | 57 | 0.060 |
Why?
| | Infectious Disease Medicine | 1 | 2023 | 10 | 0.060 |
Why?
| | Early Diagnosis | 1 | 2005 | 216 | 0.060 |
Why?
| | Superoxides | 1 | 2004 | 214 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 262 | 0.050 |
Why?
| | Ultrasonography | 1 | 2005 | 629 | 0.050 |
Why?
| | Coronavirus Infections | 1 | 2006 | 332 | 0.050 |
Why?
| | Knowledge | 1 | 2021 | 49 | 0.050 |
Why?
| | Polymerase Chain Reaction | 3 | 2008 | 994 | 0.040 |
Why?
| | Time Factors | 2 | 2016 | 6124 | 0.040 |
Why?
| | Schools, Medical | 2 | 2014 | 120 | 0.040 |
Why?
| | Discriminant Analysis | 1 | 2020 | 37 | 0.040 |
Why?
| | Health Resources | 1 | 2021 | 122 | 0.040 |
Why?
| | Infant, Newborn | 3 | 2019 | 5034 | 0.040 |
Why?
| | Risk Factors | 2 | 2018 | 8626 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 228 | 0.040 |
Why?
| | Education, Medical | 1 | 2021 | 216 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2020 | 3004 | 0.040 |
Why?
| | Biomarkers | 2 | 2020 | 3414 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 718 | 0.040 |
Why?
| | Administration, Oral | 1 | 2019 | 731 | 0.040 |
Why?
| | Learning | 1 | 2021 | 351 | 0.040 |
Why?
| | Urban Health | 1 | 2016 | 73 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2005 | 1477 | 0.030 |
Why?
| | United States | 3 | 2019 | 12176 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 560 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1690 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 17808 | 0.030 |
Why?
| | Canada | 1 | 2016 | 322 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1846 | 0.030 |
Why?
| | Particle Size | 1 | 2016 | 317 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1795 | 0.030 |
Why?
| | Diastole | 1 | 2015 | 131 | 0.030 |
Why?
| | Systole | 1 | 2015 | 171 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2016 | 440 | 0.030 |
Why?
| | Adenoviridae | 1 | 2015 | 185 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2021 | 833 | 0.030 |
Why?
| | Physicians | 1 | 2021 | 772 | 0.030 |
Why?
| | Health Surveys | 1 | 2014 | 443 | 0.030 |
Why?
| | Needs Assessment | 1 | 2014 | 313 | 0.030 |
Why?
| | Exanthema | 1 | 2013 | 74 | 0.030 |
Why?
| | Risk Assessment | 1 | 2021 | 2973 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2013 | 135 | 0.020 |
Why?
| | Prevalence | 2 | 2008 | 2249 | 0.020 |
Why?
| | gamma-Glutamyltransferase | 1 | 2011 | 42 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2015 | 618 | 0.020 |
Why?
| | Bilirubin | 1 | 2011 | 88 | 0.020 |
Why?
| | Aspartate Aminotransferases | 1 | 2011 | 86 | 0.020 |
Why?
| | Societies, Medical | 1 | 2014 | 663 | 0.020 |
Why?
| | Alanine Transaminase | 1 | 2011 | 141 | 0.020 |
Why?
| | Echocardiography | 1 | 2012 | 554 | 0.020 |
Why?
| | Peer Group | 1 | 2010 | 201 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6216 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2013 | 632 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 4899 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2481 | 0.020 |
Why?
| | Enterovirus | 1 | 2008 | 72 | 0.020 |
Why?
| | Meningitis, Aseptic | 1 | 2007 | 15 | 0.020 |
Why?
| | Virus Cultivation | 1 | 2007 | 25 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 3334 | 0.020 |
Why?
| | Cerebrospinal Fluid | 1 | 2007 | 90 | 0.020 |
Why?
| | Paralysis | 1 | 2007 | 66 | 0.020 |
Why?
| | Patient Admission | 1 | 2008 | 175 | 0.020 |
Why?
| | Clinical Clerkship | 1 | 2007 | 72 | 0.020 |
Why?
| | Multiple Organ Failure | 1 | 2007 | 142 | 0.020 |
Why?
| | Incidence | 1 | 2012 | 2312 | 0.020 |
Why?
| | Respiratory System | 1 | 2007 | 137 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9089 | 0.020 |
Why?
| | Program Evaluation | 1 | 2010 | 822 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 912 | 0.020 |
Why?
| | Encephalitis | 1 | 2007 | 127 | 0.020 |
Why?
| | Gastrointestinal Tract | 1 | 2007 | 169 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2007 | 728 | 0.010 |
Why?
| | RNA, Viral | 1 | 2006 | 566 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2008 | 2538 | 0.010 |
Why?
| | Middle Aged | 1 | 2014 | 26746 | 0.010 |
Why?
| | Adult | 1 | 2014 | 30543 | 0.010 |
Why?
|
|
Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|